CD274 and triple-negative breast carcinoma: Co-blockade of PD-1 and PD-L1 in triple-negative breast cancer can upregulate the expression of immune checkpoints (e.g., CTLA-4, TIM-3, LAG-3) on Tregs, which could potentially lead to more severe T cell dysfunction through other co-inhibitory molecules expression (97).